Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOHN A TRAYNHAM

Allopathic & Osteopathic Physicians Pediatrics

NPI
1073562500
CMS profile
48256
Location
CHARLESTON, SC

General Payments · PY2018–2024

$4,227.13

  • Reported across 194 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$872.57

34 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $872.57 34

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Supernus Pharmaceuticals, Inc. $279.90 8
GlaxoSmithKline, LLC. $127.91 7
Corium, Inc. $122.58 4
PFIZER INC. $101.29 4
IRONSHORE PHARMACEUTICALS INC. $66.41 4
SANOFI-AVENTIS U.S. LLC $61.38 2
Verrica Pharmaceuticals Inc. $48.73 2
Seqirus USA Inc $41.56 2
SOBI, INC $22.81 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,038.22 26
PY2019 $398.66 29
PY2020 $305.92 20
PY2021 $620.81 32
PY2022 $358.90 19
PY2023 $632.05 34
PY2024 $872.57 34

Payment records · PY2024 (34)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Corium, LLC $33.02 01/18/2024 Food and Beverage Undisputed 01/23/2026 1100071879 CMS
Corium, LLC $28.76 03/07/2024 Food and Beverage Undisputed 01/23/2026 1100076763 CMS
Corium, LLC $28.86 07/09/2024 Food and Beverage Undisputed 01/23/2026 1100198968 CMS
Corium, LLC $31.94 09/03/2024 Food and Beverage Undisputed 01/23/2026 1100203136 CMS
GlaxoSmithKline, LLC. $18.90 01/19/2024 Food and Beverage Undisputed 01/23/2026 1116366620 CMS
GlaxoSmithKline, LLC. $17.70 02/19/2024 Food and Beverage Undisputed 01/23/2026 1116654371 CMS
GlaxoSmithKline, LLC. $18.91 03/28/2024 Food and Beverage Undisputed 01/23/2026 1116575362 CMS
GlaxoSmithKline, LLC. $20.20 04/29/2024 Food and Beverage Undisputed 01/23/2026 1116223232 CMS
GlaxoSmithKline, LLC. $21.94 06/12/2024 Food and Beverage Undisputed 01/23/2026 1116347720 CMS
GlaxoSmithKline, LLC. $16.87 07/15/2024 Food and Beverage Undisputed 01/23/2026 1116368113 CMS
GlaxoSmithKline, LLC. $13.39 09/30/2024 Food and Beverage Undisputed 01/23/2026 1116080790 CMS
IRONSHORE PHARMACEUTICALS INC. $19.91 01/16/2024 Food and Beverage Undisputed 01/23/2026 1146270794 CMS
IRONSHORE PHARMACEUTICALS INC. $14.06 05/22/2024 Food and Beverage Undisputed 01/23/2026 1146271044 CMS
IRONSHORE PHARMACEUTICALS INC. $18.07 09/24/2024 Food and Beverage Undisputed 01/23/2026 1146293116 CMS
IRONSHORE PHARMACEUTICALS INC. $14.37 11/19/2024 Food and Beverage Undisputed 01/23/2026 1146304189 CMS
PFIZER INC. $20.13 01/08/2024 Food and Beverage Undisputed 01/23/2026 1130989445 CMS
PFIZER INC. $22.68 05/20/2024 Food and Beverage Undisputed 01/23/2026 1131410998 CMS
PFIZER INC. $29.04 05/21/2024 Food and Beverage Undisputed 01/23/2026 1131556799 CMS
PFIZER INC. $29.44 07/30/2024 Food and Beverage Undisputed 01/23/2026 1131884965 CMS
SANOFI-AVENTIS U.S. LLC $31.86 04/23/2024 Food and Beverage Undisputed 01/23/2026 1139666460 CMS
SANOFI-AVENTIS U.S. LLC $29.52 10/15/2024 Food and Beverage Undisputed 01/23/2026 1139666516 CMS
Seqirus USA Inc $21.75 03/19/2024 Food and Beverage Undisputed 01/23/2026 1125639717 CMS
Seqirus USA Inc $19.81 11/05/2024 Food and Beverage Undisputed 01/23/2026 1125639731 CMS
SOBI, INC $22.81 06/06/2024 Food and Beverage Undisputed 01/23/2026 1141424293 CMS
Supernus Pharmaceuticals, Inc. $119.88 01/05/2024 Food and Beverage Undisputed 01/23/2026 1147839825 CMS
Supernus Pharmaceuticals, Inc. $16.20 02/23/2024 Food and Beverage Undisputed 01/23/2026 1147839819 CMS
Supernus Pharmaceuticals, Inc. $23.97 04/01/2024 Food and Beverage Undisputed 01/23/2026 1147804670 CMS
Supernus Pharmaceuticals, Inc. $23.97 06/03/2024 Food and Beverage Undisputed 01/23/2026 1147804672 CMS
Supernus Pharmaceuticals, Inc. $23.97 08/08/2024 Food and Beverage Undisputed 01/23/2026 1147839821 CMS
Supernus Pharmaceuticals, Inc. $23.97 10/07/2024 Food and Beverage Undisputed 01/23/2026 1147839823 CMS
Supernus Pharmaceuticals, Inc. $23.97 11/04/2024 Food and Beverage Undisputed 01/23/2026 1147804674 CMS
Supernus Pharmaceuticals, Inc. $23.97 12/03/2024 Food and Beverage Undisputed 01/23/2026 1147804676 CMS
Verrica Pharmaceuticals Inc. $22.70 03/18/2024 Food and Beverage Undisputed 01/23/2026 1118387666 CMS
Verrica Pharmaceuticals Inc. $26.03 05/24/2024 Food and Beverage Undisputed 01/23/2026 1118387668 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.